Comment on Jankovic et al. Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. Medicina 2024, 60, 1059
Conflicts of Interest
References
- Jankovic, S.; Rovcanin, M.; Tomic, A.; Jurisic, A.; Milovanovic, Z.; Zamurovic, M. Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. Medicina 2024, 60, 1059. [Google Scholar] [CrossRef] [PubMed]
- Jankovic, S.; Rovcanin, M.; Zamurovic, M.; Jovanovic, B.; Raicevic, T.; Tomic, A. Multifaceted Impact of CO2 Laser Therapy on Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy and Sexual Function. Healthcare 2024, 12, 1385. [Google Scholar] [CrossRef] [PubMed]
- Li, F.G.; Maheux-Lacroix, S.; Deans, R.; Nesbitt-Hawes, E.; Budden, A.; Nguyen, K.; Lim, C.Y.; Song, S.; McCormack, L.; Lyons, S.D.; et al. Effect of Fractional Carbon Dioxide Laser vs. Sham Treatment on Symptom Severity in Women with Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial. JAMA 2021, 326, 1381–1389. [Google Scholar] [CrossRef] [PubMed]
- Cruff, J.; Khandwala, S. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause. J. Sex. Med. 2021, 18, 761–769. [Google Scholar] [CrossRef] [PubMed]
- Page, A.S.; Verbakel, J.Y.; Verhaeghe, J.; Latul, Y.P.; Housmans, S.; Deprest, J. Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial. BJOG 2023, 130, 312–319. [Google Scholar] [CrossRef] [PubMed]
- Ni, Y.; Lian, J. Carbon dioxide laser therapy for the management of genitourinary syndrome of menopause: A meta-analysis of randomized controlled trials. Exp. Ther. Med. 2024, 27, 10. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Broomfield, C.; Li, F.; Abbott, J. Comment on Jankovic et al. Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. Medicina 2024, 60, 1059. Medicina 2025, 61, 831. https://doi.org/10.3390/medicina61050831
Broomfield C, Li F, Abbott J. Comment on Jankovic et al. Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. Medicina 2024, 60, 1059. Medicina. 2025; 61(5):831. https://doi.org/10.3390/medicina61050831
Chicago/Turabian StyleBroomfield, Catherine, Fiona Li, and Jason Abbott. 2025. "Comment on Jankovic et al. Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. Medicina 2024, 60, 1059" Medicina 61, no. 5: 831. https://doi.org/10.3390/medicina61050831
APA StyleBroomfield, C., Li, F., & Abbott, J. (2025). Comment on Jankovic et al. Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. Medicina 2024, 60, 1059. Medicina, 61(5), 831. https://doi.org/10.3390/medicina61050831